We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$1.99B
AUM Growth
+$284M
Cap. Flow
+$258M
Cap. Flow %
12.95%
Top 10 Hldgs %
13.22%
Holding
2,248
New
441
Increased
650
Reduced
654
Closed
492

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$11.9M
2
PODD icon
Insulet
PODD
+$11.1M
3
ZEN
ZENDESK INC
ZEN
+$10.8M
4
PFPT
Proofpoint, Inc.
PFPT
+$10.7M
5
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$10.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$59.2M
2
GDDY icon
GoDaddy
GDDY
+$10.6M
3
PANW icon
Palo Alto Networks
PANW
+$10.5M
4
C icon
Citigroup
C
+$8.89M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$7.64M

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Consumer Discretionary 13.01%
3 Healthcare 12.59%
4 Industrials 12.57%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCH
1701
DELISTED
Arch Resources, Inc.
ARCH
$24K ﹤0.01%
300
-859
-74% -$73.2K
UNIT
1702
Uniti Group
UNIT
$2.33B
$22K ﹤0.01%
+1,107
New +$21.5K
LUV icon
1703
Southwest Airlines
LUV
$23B
$20K ﹤0.01%
400
-1,900
-83% -$100K
ALNY icon
1704
Alnylam Pharmaceuticals
ALNY
$28.9B
$19K ﹤0.01%
191
-2,735
-93% -$271K
BTAI icon
1705
BioXcel Therapeutics
BTAI
$25.6M
$19K ﹤0.01%
+127
New +$19.4K
HOV icon
1706
Hovnanian Enterprises
HOV
$789M
$19K ﹤0.01%
458
+334
+269% +$15.8K
PCAR icon
1707
PACCAR
PCAR
$69.5B
$19K ﹤0.01%
450
-7,560
-94% -$327K
APPN icon
1708
Appian
APPN
$2.23B
$18K ﹤0.01%
+499
New +$15.5K
HOUS
1709
DELISTED
Anywhere Real Estate
HOUS
$18K ﹤0.01%
800
-6,153
-88% -$153K
MX icon
1710
Magnachip Semiconductor
MX
$141M
$17K ﹤0.01%
1,665
-3,095
-65% -$32K
CFMS
1711
DELISTED
Conformis, Inc. Common Stock
CFMS
$16K ﹤0.01%
+510
New +$17.6K
GEN
1712
DELISTED
Genesis Healthcare, Inc.
GEN
$16K ﹤0.01%
7,100
-10,137
-59% -$19.6K
INVX
1713
Innovex International
INVX
$2.15B
$15K ﹤0.01%
+300
New +$14K
FANG icon
1714
Diamondback Energy
FANG
$53.1B
$14K ﹤0.01%
108
-15,690
-99% -$1.95M
P
1715
DELISTED
Pandora Media Inc
P
$13K ﹤0.01%
1,702
-54,368
-97% -$363K
XERS icon
1716
Xeris Biopharma Holdings
XERS
$1.27B
$12K ﹤0.01%
+645
New +$12.5K
TLND
1717
DELISTED
Talend S.A. American Depositary Shares
TLND
$12K ﹤0.01%
+200
New +$10.9K
EE
1718
DELISTED
El Paso Electric Company
EE
$12K ﹤0.01%
+200
New +$10.9K
EPRT icon
1719
Essential Properties Realty Trust
EPRT
$6.62B
$11K ﹤0.01%
+807
New +$11K
MYGN icon
1720
Myriad Genetics
MYGN
$304M
$11K ﹤0.01%
300
-4,804
-94% -$162K
CPE
1721
DELISTED
Callon Petroleum Company
CPE
$11K ﹤0.01%
100
-1,365
-93% -$169K
NEX
1722
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$11K ﹤0.01%
834
-11,740
-93% -$176K
DNTH icon
1723
Dianthus Therapeutics
DNTH
$6.15B
$10K ﹤0.01%
+47
New +$10.6K
AGTC
1724
DELISTED
Applied Genetic Technologies Corporation
AGTC
$10K ﹤0.01%
+2,710
New +$12.5K
TFCFA
1725
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$10K ﹤0.01%
+200
New +$7.9K
67 68
69
70 71

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2018 Portfolio in Review

As of Q2 2018, Cubist Systematic Strategies held 2,248 positions worth $1.99B, up 17% from $1.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cubist Systematic Strategies deployed $258M of net new capital in Q2 2018, opening 441 new positions and adding to 650 existing holdings. Its largest new stake was Sage Therapeutics: 76,110 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.2M trimmed.

  • Cubist Systematic Strategies's largest Q2 2018 buy was Sage Therapeutics: 76,110 shares worth $11.9M.
  • Cubist Systematic Strategies added most to ZENDESK INC in Q2 2018, an estimated $10.8M increase.
  • Cubist Systematic Strategies's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.2M.
  • Cubist Systematic Strategies fully exited TJX Companies in Q2 2018, selling an estimated $6.46M.
  • Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.99B portfolio in Q2 2018.
  • Cubist Systematic Strategies opened 441 new positions and closed 492 in Q2 2018.
  • Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $1.99B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.